Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain

被引:241
作者
Mogi, M
Togari, A
Kondo, T
Mizuno, Y
Komure, O
Kuno, S
Ichinose, H
Nagatsu, T [1 ]
机构
[1] Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan
[2] Natl Utano Hosp, Dept Neurol, Kyoto, Japan
[3] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan
[4] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan
[5] Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Nagoya, Aichi 464, Japan
关键词
caspase-1; caspase-3; tumor necrosis factor receptor R1 (p55); Parkinson's disease; brain;
D O I
10.1007/s007020050028
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The activities of caspase-1 and caspase-3 were measured by use of fluoropeptides as substrates for the first time in the brain (substantia nigra, caudate nucleus, putamen, cerebellum, and frontal cortex) from control and parkinsonian patients. The activities of caspases in the brain were significantly higher in the substantia nigra from parkinsonian patients than those in the brain from control patients (p < 0.01). However, the activities of caspases in the caudate nucleus, putamen, cerebellum, and frontal cortex showed no significant difference between parkinsonian and control patients. The tumor necrosis factor (TNF) receptor R1 (TNF-R1, p55) level was also elevated in the substantia nigra of the parkinsonian brain in comparison with that of controls (p < 0.05). Since both caspases and TNF-R1 may play important roles in apoptotic cell death through! TNF-alpha-induced signaling pathway, our present data suggest the presence of a proapoptotic environment in the substantia nigra of parkinsonian brain, probably inducing vulnerability of neurons and glias towards a variety of noxious factors.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 26 条
[1]  
Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
[2]  
Anglade P, 1997, HISTOL HISTOPATHOL, V12, P603
[3]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[4]   IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[5]   Apoptosis in neuronal development and transplantation: Role of caspases and trophic factors [J].
Boonman, Z ;
Isacson, O .
EXPERIMENTAL NEUROLOGY, 1999, 156 (01) :1-15
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME [J].
CERRETTI, DP ;
KOZLOSKY, CJ ;
MOSLEY, B ;
NELSON, N ;
VANNESS, K ;
GREENSTREET, TA ;
MARCH, CJ ;
KRONHEIM, SR ;
DRUCK, T ;
CANNIZZARO, LA ;
HUEBNER, K ;
BLACK, RA .
SCIENCE, 1992, 256 (5053) :97-100
[8]   Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis [J].
Enari, M ;
Talanian, RV ;
Wong, WW ;
Nagata, S .
NATURE, 1996, 380 (6576) :723-726
[9]   Inhibition of ICE slows ALS in mice [J].
Friedlander, RM ;
Brown, RH ;
Gagliardini, V ;
Wang, J ;
Yuan, JY .
NATURE, 1997, 388 (6637) :31-31
[10]   Is there apoptosis in Lewy body disease? [J].
Jellinger, KA .
ACTA NEUROPATHOLOGICA, 1999, 97 (04) :413-415